Details
Stereochemistry | ACHIRAL |
Molecular Formula | Zn |
Molecular Weight | 65.3956 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[Zn]
InChI
InChIKey=HCHKCACWOHOZIP-UHFFFAOYSA-N
InChI=1S/Zn
Molecular Formula | Zn |
Molecular Weight | 65.3956 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
DescriptionCurator's Comment:: Description was created based on several sources, including http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/50168slr078_cotisporin_lbl.pdf
Curator's Comment:: Description was created based on several sources, including http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/50168slr078_cotisporin_lbl.pdf
Bacitracin is a polypeptide antibiotic produced by Bacillus subtilis and Bacillus licheniformis. Bacitracin in combination with neomycin and polymyxin B is indicated for the treatment of many bacterial diseases. The antibacterial properties of bacitracin are mediated by its binding to C55-isoprenyl pyrophosphate, resulting in inhibition of cell wall biosynthesis.
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL2364036 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Curative | BACITRACIN Approved UseUses first aid to help prevent infection in: •minor cuts •scrapes •burns Launch Date-6.7616637E11 |
|||
Curative | CORTISPORIN Approved UseFor the treatment of corticosteroid-responsice dermatoses with secondary infection. Launch Date-4.0417919E11 |
|||
Curative | NEOSPORIN Approved UseNEOSPORIN Ophthalmic Ointment is indicated for the topical treatment of superficial infections of the external eye and its adnexa caused by susceptible bacteria. Such infections encompass conjunctivitis, keratitis and keratoconjunctivitis, blepharitis and blepharoconjunctivitis. Launch Date-4.7260799E10 |
PubMed
Title | Date | PubMed |
---|---|---|
Bacitracin: Methods of Production, Concentration, and Partial Purification, with a Summary of the Chemical Properties of Crude Bacitracin. | 1948 Feb |
|
The relative antisyphilitic activity of penicillins F,G,K, and X and of bacitracin, based on the amounts required to abort early syphilic infections in rabbits. | 1948 Mar |
|
The Action of Bacitracin and Subtilin on Treponema pallidum in Vitro and in Vivo. | 1948 Mar |
|
The Results of the Systemic Administration of the Antibiotic, Bacitracin, in Surgical Infections: A Preliminary Report. | 1948 Oct |
|
A Note on the Susceptibility of Hemophilus influenzae Type B to Bacitracin. | 1948 Oct |
|
The Use of Bacitracin in Experimental Clostridium Welchii Infection in Guinea Pigs. | 1949 Oct |
|
IN VITRO STUDIES ON POSSIBLE SYNERGISTIC ACTION BETWEEN PENICILLIN AND BACITRACIN. | 1949 Sep |
|
In vitro sensitivity of Bacillus proteus and Pseudomonas aeruginosa to seven antibiotics; penicillin, streptomycin, bacitracin, polymyxin, aerosporin, aureomycin, and chloromycetin. | 1950 Feb |
|
Systemic bacitracin in the treatment of progressive bacterial synergistic gangrene. | 1950 Feb |
|
Detection by HPLC-ICP of metallothionein in serum of an epileptic child with valproate-associated hepatotoxicity. | 1992 Dec |
|
Differential dephosphorylation of the insulin receptor and its 160-kDa substrate (pp160) in rat adipocytes. | 1992 Jul 15 |
|
[Effect of zinc deficiency and zinc replenishment on HOX3.5 gene expression in mouse embryos]. | 2001 Nov |
|
Metallothionein is required for zinc-induced expression of the macrophage colony stimulating factor gene. | 2002 |
|
p53 protein and p21 mRNA levels and caspase-3 activity are altered by zinc status in aortic endothelial cells. | 2002 Aug |
|
Zinc depletion reduced Egr-1 and HNF-3beta expression and apolipoprotein A-I promoter activity in Hep G2 cells. | 2002 Aug |
|
Isolation of GIF from porcine brain and studies of its zinc transfer kinetics with apo-carbonic anhydrase. | 2002 Dec |
|
Zinc-dependent interaction between dishevelled and the Drosophila Wnt antagonist naked cuticle. | 2002 Dec 13 |
|
Purification and characterization of cytosolic glycerol-3-phosphate dehydrogenase from skeletal muscle of jerboa (Jaculus orientalis). | 2002 Feb |
|
S-nitrosothiols react preferentially with zinc thiolate clusters of metallothionein III through transnitrosation. | 2002 Jul 2 |
|
Src-dependent phosphorylation of the epidermal growth factor receptor on tyrosine 845 is required for zinc-induced Ras activation. | 2002 Jul 5 |
|
Partitioning of accumulated trace metals in the talitrid amphipod crustacean Orchestia gammarellus: a cautionary tale on the use of metallothionein-like proteins as biomarkers. | 2002 Jun |
|
Co-assembly of GABA rho subunits with the GABA(A) receptor gamma(2) subunit cloned from white perch retina. | 2002 Jun 30 |
|
White-sided dolphin metallothioneins: purification, characterisation and potential role. | 2002 Mar |
|
Zinc inhibits nuclear factor-kappa B activation and sensitizes prostate cancer cells to cytotoxic agents. | 2002 Nov |
|
Zinc transporters in the rat mammary gland respond to marginal zinc and vitamin A intakes during lactation. | 2002 Nov |
|
Zinc enhances the expression of interleukin-2 and interleukin-2 receptors in HUT-78 cells by way of NF-kappaB activation. | 2002 Oct |
|
Metalloenzyme-like activity of Alzheimer's disease beta-amyloid. Cu-dependent catalytic conversion of dopamine, cholesterol, and biological reducing agents to neurotoxic H(2)O(2). | 2002 Oct 25 |
|
Evidence for non-isostructural replacement of Zn(2+) with Cd(2+) in the beta-domain of brain-specific metallothionein-3. | 2002 Sep 11 |
|
Induction of metallothionein by zinc protects from daunorubicin toxicity in rats. | 2002 Sep 30 |
|
Changes in rat hepatic gene expression in response to zinc deficiency as assessed by DNA arrays. | 2003 Apr |
|
Zinc deficiency induces oxidative DNA damage and increases p53 expression in human lung fibroblasts. | 2003 Aug |
|
Human ZIP1 is a major zinc uptake transporter for the accumulation of zinc in prostate cells. | 2003 Aug 1 |
|
Mechanisms of Zn(2+)-induced signal initiation through the epidermal growth factor receptor. | 2003 Aug 15 |
|
Redox labile site in a Zn4 cluster of Cu4,Zn4-metallothionein-3. | 2003 Aug 19 |
|
Human peptidoglycan recognition protein-L is an N-acetylmuramoyl-L-alanine amidase. | 2003 Dec 5 |
|
Indomethacin-induced free radical-mediated changes in the intestinal brush border membranes. | 2003 Feb 15 |
|
The permissive effect of zinc deficiency on uroguanylin and inducible nitric oxide synthase gene upregulation in rat intestine induced by interleukin 1alpha is rapidly reversed by zinc repletion. | 2003 Jan |
|
Pancreatic metallothionein-I may play a role in zinc homeostasis during maternal dietary zinc deficiency in mice. | 2003 Jan |
|
p53 deficiency accelerates induction and progression of esophageal and forestomach tumors in zinc-deficient mice. | 2003 Jan 1 |
|
A novel class of ligand-gated ion channel is activated by Zn2+. | 2003 Jan 10 |
|
Differential effects of zinc on functionally distinct human growth hormone mutations. | 2003 Jul |
|
Chromium(VI) down-regulates heavy metal-induced metallothionein gene transcription by modifying transactivation potential of the key transcription factor, metal-responsive transcription factor 1. | 2003 Jul 11 |
|
In vitro effect of metal ions on the activity of two amphibian glyceraldehyde-3-phosphate dehydrogenases: potential metal binding sites. | 2003 Jun |
|
Interaction of Tl+ with product complexes of fructose-1,6-bisphosphatase. | 2003 May 2 |
|
Regulated cell surface pro-EGF ectodomain shedding is a zinc metalloprotease-dependent process. | 2003 Nov 14 |
|
Zinc modulates PPARgamma signaling and activation of porcine endothelial cells. | 2003 Oct |
|
Identification of human intestinal alkaline sphingomyelinase as a novel ecto-enzyme related to the nucleotide phosphodiesterase family. | 2003 Oct 3 |
|
Purification of recombinant human apometallothionein-3 and reconstitution with zinc. | 2003 Sep |
|
Heparin-binding epidermal growth factor cleavage mediates zinc-induced epidermal growth factor receptor phosphorylation. | 2004 Apr |
|
Bacitracin Inhibits the Migration of U87-MG Glioma Cells via Interferences of the Integrin Outside-in Signaling Pathway. | 2016 Mar |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/50168slr078_cotisporin_lbl.pdf
Curator's Comment:: Bacitracin can be used as ophtalmic solution (0.025mg/ml) for the treatment of superficial ocular infections.
400 units, topically
Route of Administration:
Topical
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Jun 26 12:10:43 UTC 2021
by
admin
on
Sat Jun 26 12:10:43 UTC 2021
|
Record UNII |
J41CSQ7QDS
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C896
Created by
admin on Sat Jun 26 12:10:43 UTC 2021 , Edited by admin on Sat Jun 26 12:10:43 UTC 2021
|
||
|
CFR |
21 CFR 101.71
Created by
admin on Sat Jun 26 12:10:43 UTC 2021 , Edited by admin on Sat Jun 26 12:10:43 UTC 2021
|
||
|
EMA ASSESSMENT REPORTS |
WILZIN (AUTHOIRIZED: HEPATOLENTICAL DEGENERATION)
Created by
admin on Sat Jun 26 12:10:43 UTC 2021 , Edited by admin on Sat Jun 26 12:10:43 UTC 2021
|
||
|
CFR |
21 CFR 176.170
Created by
admin on Sat Jun 26 12:10:43 UTC 2021 , Edited by admin on Sat Jun 26 12:10:43 UTC 2021
|
||
|
EPA PESTICIDE CODE |
129015
Created by
admin on Sat Jun 26 12:10:43 UTC 2021 , Edited by admin on Sat Jun 26 12:10:43 UTC 2021
|
||
|
NCI_THESAURUS |
C637
Created by
admin on Sat Jun 26 12:10:43 UTC 2021 , Edited by admin on Sat Jun 26 12:10:43 UTC 2021
|
||
|
WHO-ATC |
C05AX04
Created by
admin on Sat Jun 26 12:10:43 UTC 2021 , Edited by admin on Sat Jun 26 12:10:43 UTC 2021
|
||
|
WHO-ATC |
S01AX03
Created by
admin on Sat Jun 26 12:10:43 UTC 2021 , Edited by admin on Sat Jun 26 12:10:43 UTC 2021
|
||
|
CFR |
21 CFR 102.23
Created by
admin on Sat Jun 26 12:10:43 UTC 2021 , Edited by admin on Sat Jun 26 12:10:43 UTC 2021
|
||
|
WHO-ATC |
D09AB02
Created by
admin on Sat Jun 26 12:10:43 UTC 2021 , Edited by admin on Sat Jun 26 12:10:43 UTC 2021
|
||
|
LIVERTOX |
1049
Created by
admin on Sat Jun 26 12:10:43 UTC 2021 , Edited by admin on Sat Jun 26 12:10:43 UTC 2021
|
||
|
DSLD |
137 (Number of products:9660)
Created by
admin on Sat Jun 26 12:10:43 UTC 2021 , Edited by admin on Sat Jun 26 12:10:43 UTC 2021
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
7440-66-6
Created by
admin on Sat Jun 26 12:10:43 UTC 2021 , Edited by admin on Sat Jun 26 12:10:43 UTC 2021
|
PRIMARY | |||
|
C948
Created by
admin on Sat Jun 26 12:10:43 UTC 2021 , Edited by admin on Sat Jun 26 12:10:43 UTC 2021
|
PRIMARY | |||
|
23994
Created by
admin on Sat Jun 26 12:10:43 UTC 2021 , Edited by admin on Sat Jun 26 12:10:43 UTC 2021
|
PRIMARY | |||
|
1344
Created by
admin on Sat Jun 26 12:10:43 UTC 2021 , Edited by admin on Sat Jun 26 12:10:43 UTC 2021
|
PRIMARY | |||
|
SUB130055
Created by
admin on Sat Jun 26 12:10:43 UTC 2021 , Edited by admin on Sat Jun 26 12:10:43 UTC 2021
|
ALTERNATIVE | |||
|
7440-66-6
Created by
admin on Sat Jun 26 12:10:43 UTC 2021 , Edited by admin on Sat Jun 26 12:10:43 UTC 2021
|
PRIMARY | |||
|
231-175-3
Created by
admin on Sat Jun 26 12:10:43 UTC 2021 , Edited by admin on Sat Jun 26 12:10:43 UTC 2021
|
PRIMARY | |||
|
11416
Created by
admin on Sat Jun 26 12:10:43 UTC 2021 , Edited by admin on Sat Jun 26 12:10:43 UTC 2021
|
PRIMARY | |||
|
SUB12619MIG
Created by
admin on Sat Jun 26 12:10:43 UTC 2021 , Edited by admin on Sat Jun 26 12:10:43 UTC 2021
|
PRIMARY | |||
|
D015032
Created by
admin on Sat Jun 26 12:10:43 UTC 2021 , Edited by admin on Sat Jun 26 12:10:43 UTC 2021
|
PRIMARY | |||
|
DB01593
Created by
admin on Sat Jun 26 12:10:43 UTC 2021 , Edited by admin on Sat Jun 26 12:10:43 UTC 2021
|
PRIMARY | |||
|
253210
Created by
admin on Sat Jun 26 12:10:43 UTC 2021 , Edited by admin on Sat Jun 26 12:10:43 UTC 2021
|
ALTERNATIVE | |||
|
J41CSQ7QDS
Created by
admin on Sat Jun 26 12:10:43 UTC 2021 , Edited by admin on Sat Jun 26 12:10:43 UTC 2021
|
PRIMARY | |||
|
M11596
Created by
admin on Sat Jun 26 12:10:43 UTC 2021 , Edited by admin on Sat Jun 26 12:10:43 UTC 2021
|
PRIMARY | Merck Index |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
Nutritional value per 100 g (3.5 oz) - 0.41 mg (4%)
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |